Abstract
Antibody-dependent cellular cytotoxicity (ADCC), a lytic attack on antibody-targeted cells, is triggered upon binding of lymphocyte receptors (FcgammaRs) to the antibody constant region. ADCC is considered to be a major therapeutic function of antibodies. ADCC requires the presence of oligosaccharides in the Fc region and is sensitive to change in the oligosaccharide structure. We have demonstrated that fucose is the most critical IgG1 oligosaccharide component, and the removal of fucose from IgG1 oligosaccharides results in a very significant enhancement of ADCC and anti-tumor activity in vivo. Many therapeutic antibodies approved or clinical development are produced using Chinese hamster ovary (CHO) cells that express high level of alpha1,6-fucosyltransferase and consequently produce highly fucosylated antibodies. We have established the fucosyltransferase knockout CHO cells which could stably produce non-fucosylated antibodies, designated as Potelligent antibodies. Potelligent antibodies show potent ADCC upon target cells through the effective and antigen-specific activation of NK cells due to augmented binding to FcgammaRIIIa. Moreover, Potelligent antibodies can evade the inhibitory effect of plasma IgG on ADCC through its...Continue Reading
References
Aug 1, 1987·Analytical Biochemistry·H HaradaA Kobata
Mar 3, 1999·Nature Biotechnology·P UmañaJ E Bailey
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Nov 30, 2000·The Journal of Biological Chemistry·R L ShieldsL G Presta
Jan 25, 2002·Blood·Guillaume CartronHervé Watier
May 3, 2002·The Journal of Biological Chemistry·Robert L ShieldsLeonard G Presta
Nov 13, 2002·The Journal of Biological Chemistry·Toyohide ShinkawaKenya Shitara
Mar 18, 2004·Cancer Research·Rinpei NiwaKenya Shitara
Mar 24, 2004·Journal of Molecular Biology·Akira OkazakiKenya Shitara
Sep 8, 2004·Biotechnology and Bioengineering·Naoko Yamane-OhnukiMitsuo Satoh
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roberto GennariAlberto Costa
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rinpei NiwaKenya Shitara
Oct 30, 2004·Biotechnology and Bioengineering·Katsuhiro MoriMitsuo Satoh
Mar 25, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rinpei NiwaKenya Shitara
Apr 13, 2006·Biotechnology and Bioengineering·Yutaka KandaMitsuo Satoh
May 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shigeru IidaMitsuo Satoh
Oct 3, 2006·Molecular Immunology·Andreas NechanskyRalf Kircheis
Mar 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eiji SuzukiMasakazu Toi
Mar 21, 2007·Journal of Molecular Biology·Shigeki MatsumiyaKoichi Kato
Citations
Sep 8, 2011·Cancer Science·Tadaaki YamadaSeiji Yano
Nov 23, 2012·Biotechnology Progress·Seshu TummalaAnthony Rossomando
Oct 22, 2016·Archives of Toxicology·Arathi KizhedathJarka Glassey
May 4, 2011·American Journal of Human Biology : the Official Journal of the Human Biology Council·Gillian H IceElizabeth Juma
May 30, 2012·Biotechnology Progress·P A Marichal-Gallardo, M M Alvarez
Jul 1, 2014·Biotechnology and Bioengineering·Helen H Shi, Chetan T Goudar
Oct 9, 2014·The Medical Journal of Australia·Heather Kitt
Apr 5, 2014·Journal of Molecular Recognition : JMR·Simon J MountfordMilton T W Hearn
Sep 10, 2015·The Cochrane Database of Systematic Reviews·Megan K YoungMieke L van Driel
Apr 13, 2018·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Kenichiro TodorokiToshimasa Toyo'oka